GPT and anemia: Of the 233 participants enrolled, 23 (9.9%) harbored drug-resistant virus at the time of sampling, 26 (11.2%) and 52 (22.3%) had alanine aminotransferase and aspartate aminotransferase levels, respectively, and 67 (28.8%) had anemia (Table 1).